These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14619928)

  • 1. New TB antibiotic.
    AIDS Patient Care STDS; 2003 Aug; 17(8):437-8. PubMed ID: 14619928
    [No Abstract]   [Full Text] [Related]  

  • 2. Linezolid for multidrug-resistant tuberculosis.
    Chang KC; Leung CC; Daley CL
    Lancet Infect Dis; 2012 Jul; 12(7):502-3. PubMed ID: 22742623
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
    Park IN; Hong SB; Oh YM; Kim MN; Lim CM; Lee SD; Koh Y; Kim WS; Kim DS; Kim WD; Shim TS
    J Antimicrob Chemother; 2006 Sep; 58(3):701-4. PubMed ID: 16857689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linezolid for multidrug-resistant tuberculosis.
    Cox H; Ford N; Hughes J; Goemaere E
    Lancet Infect Dis; 2013 Jan; 13(1):16. PubMed ID: 23257228
    [No Abstract]   [Full Text] [Related]  

  • 5. Linezolid for multidrug-resistant tuberculosis - authors' reply.
    Chang KC; Leung CC; Daley CL
    Lancet Infect Dis; 2013 Jan; 13(1):16-7. PubMed ID: 23257227
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term linezolid treatment in a young child with extensively drug-resistant tuberculosis.
    Schaaf HS; Willemse M; Donald PR
    Pediatr Infect Dis J; 2009 Aug; 28(8):748-50. PubMed ID: 19633523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multiresistant tuberculosis caused by Mycobacterium bovis and human immunodeficiency virus infection. Are there new therapeutic possibilities?].
    Valencia ME; Moreno V; Laguna F; González-Lahoz JM
    Enferm Infecc Microbiol Clin; 2001 Jan; 19(1):37-9. PubMed ID: 11256251
    [No Abstract]   [Full Text] [Related]  

  • 8. Linezolid.
    Tuberculosis (Edinb); 2008 Mar; 88(2):122-5. PubMed ID: 18486048
    [No Abstract]   [Full Text] [Related]  

  • 9. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    Yew WW; Chang KC; Chau CH
    J Antimicrob Chemother; 2009 Nov; 64(5):1119; author reply 1119-20. PubMed ID: 19666903
    [No Abstract]   [Full Text] [Related]  

  • 10. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response.
    Koh WJ; Shim TS
    J Antimicrob Chemother; 2009 Nov; 64(5):1119-20. PubMed ID: 19744986
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of linezolid efficacy and safety in MDR- and XDR-TB: an Indian perspective.
    Udwadia ZF; Sen T; Moharil G
    Eur Respir J; 2010 Apr; 35(4):936-8; author reply 938-40. PubMed ID: 20356997
    [No Abstract]   [Full Text] [Related]  

  • 12. [New aspects in the control and treatment of chronic pulmonary tuberculosis].
    Milutinović R; Zigić M; Ilić M
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():79-86. PubMed ID: 4614297
    [No Abstract]   [Full Text] [Related]  

  • 13. On linezolid efficacy and tolerability.
    De Lorenzo S; Centis R; D'Ambrosio L; Sotgiu G; Migliori GB
    Eur Respir J; 2012 Mar; 39(3):770-2. PubMed ID: 22379150
    [No Abstract]   [Full Text] [Related]  

  • 14. A new weapon against TB?
    Ashraf H
    Drug Discov Today; 2005 Feb; 10(4):230-1. PubMed ID: 15708737
    [No Abstract]   [Full Text] [Related]  

  • 15. [Linezolid, an agent from a new class of antibiotics].
    Slebos DJ; Van Altena R
    Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2462; author reply 2462-3. PubMed ID: 15626313
    [No Abstract]   [Full Text] [Related]  

  • 16. Emergence of linezolid resistance in a methicillin resistant Staphylococcus aureus strain.
    Hentschke M; Saager B; Horstkotte MA; Scherpe S; Wolters M; Kabisch H; Grosse R; Heisig P; Aepfelbacher M; Rohde H
    Infection; 2008 Feb; 36(1):85-7. PubMed ID: 18165857
    [No Abstract]   [Full Text] [Related]  

  • 17. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    Koh WJ; Kwon OJ; Gwak H; Chung JW; Cho SN; Kim WS; Shim TS
    J Antimicrob Chemother; 2009 Aug; 64(2):388-91. PubMed ID: 19468028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxazolidinones--a new class of broad-spectrum chemotherapeutics.
    Sztanke K; Pasternak K; Sztanke M
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):335-41. PubMed ID: 16146103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Justifying research risks in a clinical trial for treatment of multidrug-resistant tuberculosis.
    Heilig CM; Chia D; El-Sadr WM; Hirsch-Moverman Y; Kenzie WR; Saukkonen J; Villarino ME; Padayatchi N
    IRB; 2011; 33(4):10-7. PubMed ID: 21932482
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bacteriologic study of primary chemoresistance in patients with pulmonary tuberculosis in the county of Iaşi over a four year period (1971-1974)].
    Timoşca S; Georgescu M; Petreanu V; Bălteanu E; Duda R
    Rev Med Chir Soc Med Nat Iasi; 1976; 80(4):561-5. PubMed ID: 16296540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.